Patents Assigned to Queen's University of Kingston
  • Patent number: 11512207
    Abstract: Polyurethane-based and epoxy-based coating compositions are described that provide coatings and adhesives that are clear, amphiphobic and durable. Both water and hexadecane readily slide off these surfaces without leaving a residue. Coatings with thicknesses ranging from about 10 nm to about 10 ?m exhibited excellent transmittance properties. Such films exhibited durability against abrasion, ink-resistance, anti-graffiti, anti-fingerprint, and strong adhesion to glass surfaces. The coatings are applicable to electronic devices, fabrics, glass, etc. to prepare optically clear, stain-resistant, and smudge-resistant surfaces.
    Type: Grant
    Filed: November 26, 2020
    Date of Patent: November 29, 2022
    Assignee: Queen's University at Kingston
    Inventors: Heng Hu, Guojun Liu, Muhammad Rabnawaz
  • Patent number: 11456165
    Abstract: In a method for spatially localizing mass-spectrometry analysis of an analyte derived from an energy event, an electrical device is used to deliver an energy event to a substrate, and the analyte produced is analyzed using mass spectrometry. Electrical signals sent to and received from the electrical device under different modes of operation are sensed and classified according to each different mode of operation. A location of the electrical device is tracked in three dimensions during the energy event, and a processor is used to perform spatial-temporal alignment of the mass-spectrometry, the determined modes of operation of the electrical device, and the tracked location of the electrical device, wherein mass spectrometry data corresponding to the determined modes of the electrical device are identified and localized within the site of the energy event. The substrate may be tissue in a surgical site, and the electrical device may be an electrocautery device.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: September 27, 2022
    Assignee: Queen's University at Kingston
    Inventors: Mark Asselin, Gabor Fichtinger
  • Patent number: 11451139
    Abstract: Three-phase single-stage AC-DC converters achieve power factor correction with low phase voltage switch stress. Direct input current sensing is performed to calculate the average input current of the AC-DC converter and implement power factor correction. Embodiments feature high power factor, single stage power conversion, and soft-switching of all switches, resulting in high conversion efficiency in a cost-effective single-stage three-phase structure. The converters have low output voltage ripple without a double line frequency component, which allows non-electrolytic capacitor implementation. The converters are particularly useful in high-power applications such as electric vehicle charging.
    Type: Grant
    Filed: January 15, 2020
    Date of Patent: September 20, 2022
    Assignees: Queen's University at Kingston, Ganpower International Inc.
    Inventors: Mojtaba Forouzesh, Xiang Zhou, Yan-Fei Liu
  • Patent number: 11396241
    Abstract: A series circuit includes a capacitor connected in series with output terminals of a power converter. The power converter provides an auxiliary voltage and a controller controls the auxiliary voltage according to a selected function, such that the series circuit behaves as a capacitor, an inductor, or an impedance, based on the selected function. The controller may sense a voltage across the capacitor and use the sensed voltage to control the auxiliary voltage according to the selected function. The series circuit may be connected in parallel with output terminals of an AC-DC converter, wherein the series circuit operates according to a selected mode to produce the auxiliary voltage, and the auxiliary voltage substantially cancels a low frequency AC voltage ripple across the capacitor, such that a substantially pure DC output voltage is delivered to the load.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: July 26, 2022
    Assignee: Queen's University at Kingston
    Inventor: Yan-Fei Liu
  • Patent number: 11394307
    Abstract: Resonant converters with wide voltage gain ranges are achieved by controlling at least one of the primary side resonant circuit and the secondary side rectifier circuit. A switch is included in at least one of the primary or secondary sides, and control of the switch according to a selected mode determines an output voltage of the resonant converter. Embodiments accommodate wide input and output voltage ranges, and are suitable for use in AC-DC power adapters for portable devices with different voltage requirements, such as cell phones, tablets, and notebook computers, as well as in DC-DC converter applications including electric vehicle power systems.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: July 19, 2022
    Assignee: Queen's University at Kingston
    Inventors: Yang Chen, Yan-Fei Liu
  • Patent number: 11383266
    Abstract: The present application provides stable, carbene-functionalized composite materials, and methods and uses thereof. These carbene-functionalized composite materials comprise a material having a metal surface, and a carbene monolayer that is uniform, contaminant-free (metal oxide, etc), and more stable than thiol-functionalized monolayers. Uses of such carbene-functionalized composite materials include semi-conducting materials, microelectronic devices, drug delivery or sensing applications.
    Type: Grant
    Filed: August 19, 2014
    Date of Patent: July 12, 2022
    Assignee: Queen's University at Kingston
    Inventors: Cathleen M. Crudden, J. Hugh Horton, Olena V. Zenkina, Iraklii I. Ebralidze, Christene Anne Smith
  • Patent number: 11369594
    Abstract: A class of compounds useful in pharmaceutical compositions and methods for treating or preventing cancer is described. Analogs of Mycalolide B have been prepared and tested in breast and ovarian cancer cell lines. The compounds show utility for inhibition of survival and proliferation of tumor cells. The compounds have been shown to disrupt actin.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: June 28, 2022
    Assignee: Queen's University at Kingston
    Inventors: Rebecca Grange, John Allingham, Andrew Craig, P. Andrew Evans, Madhu Aeluri
  • Patent number: 11364220
    Abstract: Compounds described herein are inhibitors of retinoic add inducible P450 (CYP26) enzymes, and are useful for treating diseases that are responsive to retinoids. Certain compounds have retinoid activity, are resistant to CYP26-mediated catabolism, and are used for treating diseases that are responsive to retinoids.
    Type: Grant
    Filed: November 26, 2020
    Date of Patent: June 21, 2022
    Assignee: Queen's University at Kingston
    Inventors: Donald Andrew Cameron, Martin Petkovich, Toni Kristian Rantanen, Victor Snieckus, Johnathan Board, Suneel Singh, Ashishkumar Jayantilal Maheta
  • Patent number: 11358933
    Abstract: Compounds that are inhibitors of retinoic acid inducible P450 (CYP26) enzymes. The compounds have retinoid activity, are resistant to CYP26-mediated catabolism, act as inhibitors of CYP26B1, and are used for treating diseases that are responsive to retinoids.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: June 14, 2022
    Assignee: Queen's University at Kingston
    Inventors: Donald Andrew Cameron, Martin Petkovich, Uttam Saha
  • Patent number: 11349385
    Abstract: A start-up circuit for a power converter includes a charging circuit that uses a DC bus voltage of the power converter to generate a charging current to charge an energy storage device to a selected voltage and an auxiliary power output circuit including a transformer primary side auxiliary winding. A control circuit controls one or more switches of the start-up circuit and one or more switches of the power converter primary side. The charging current provides power to the control circuit until the auxiliary power is established. The control circuit disables the start-up circuit when the auxiliary power output is established. The start-up circuit has very low standby power consumption and compact size, and is particularly suitable for power converter applications such as power adapters for portable electronic devices.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: May 31, 2022
    Assignee: Queen's University at Kingston
    Inventors: Yang Chen, Yan-Fei Liu
  • Patent number: 11344246
    Abstract: A method for detecting long QT syndrome in a subject comprises obtaining data corresponding to an electrocardiogram (ECG) signal of the subject, identifying a set of features in the data based on selected inflection points of the ECG signal, using the set of features to categorize segments of the ECG signal, and using the categorized segments of the ECG signal and the inflection points to classify the ECG signal as normal or as long QT syndrome. Long QT syndrome is detected when the subject's ECG signal is classified as long QT syndrome. The method may include determining whether the long QT syndrome is Type 1 or Type 2.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: May 31, 2022
    Assignees: Queen's University at Kingston, Kingston Health Sciences Centre
    Inventors: Habib Hajimolahoseini, Damian P. Redfearn, Javad Hashemi
  • Patent number: 11284826
    Abstract: Study of intracardiac electrograms (IEGMs) during atrial fibrillation (AF) provides clinically significant information that can be used in ablation therapy. Methods include determining a regional feature, e.g., dominant frequency (RDF), which encompasses the relationship between simultaneously recorded electrodes and identifies the feature components of a region, rather than the feature of a single electrode. Methods employing the regional feature may be used to identify and characterize variation and disorganization in wavefront propagation or wave breaks (WBs) at each recording site, and may be used to direct catheter ablation therapy.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: March 29, 2022
    Assignees: Queen's University at Kingston, Kingston Health Sciences Centre
    Inventors: Mohammad Hassan Shariat, Damian P. Redfearn
  • Patent number: 11237112
    Abstract: A surface enhanced Raman spectroscopy (SERS) device, comprises a non-electrically conductive substrate, at least two microelectrodes disposed on the substrate in a spaced relationship such that a detection site is formed along edges and/or between opposing edges of the microelectrodes, and a nanoparticle structure comprising a plurality of metallic nanoparticles disposed in the detection site. Assembly of the nanoparticle structure may be directed by an electric field between the at least two microelectrodes. The SERS device is inexpensive, robust, portable, and reusable. Also described herein are methods for using and preparing the SERS devices with simple, rapid, and inexpensive fabrication techniques.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: February 1, 2022
    Assignee: Queen's University at Kingston
    Inventors: Hannah Bacon, Aristides Docoslis, Carlos Escobedo
  • Patent number: 11236250
    Abstract: The present application provides switchable, homogeneous paint composition and methods of painting and/or forming films or coatings using the composition. The composition includes a liquid having an aqueous solution and dissolved acid gas (e.g., carbonated water), and a switchable polymer. The switchable polymer converts from a protonated, water-soluble form in the liquid to a water-insoluble unprotonated form following removal or substantial removal of the liquid and acid gas.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: February 1, 2022
    Assignee: Queen's University at Kingston
    Inventors: Rui Resendes, Philip G. Jessop, Michael F. Cunningham, Bhanu Prakash Mudraboyina, Adam Michael Ozvald, Timothy James Clark, Brian Mariampillai, Yun Yang, Amy Marie Holland, Charles Howard Honeyman
  • Patent number: 11229629
    Abstract: Pharmaceutical compositions that include inhibitors of mitochondrial fission are described for the treatment and/or mitigation of cancer, pulmonary arterial hypertension, cardioprotection, stroke, coronary heart disease, neurological disorder, a neurodegenerative disease, Parksinonism, Huntington's Chorea, Alzheimer's disease, diabetic cardiomyopathy, fatty liver diseases, non-alcoholic fatty liver diseases, or alcohol-related liver disease.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: January 25, 2022
    Assignee: Queen's University at Kingston
    Inventors: Danchen Wu, Michael Wells, Stephen Archer
  • Patent number: 11226201
    Abstract: Provided are apparatus and methods for generating a representation of a physical environment, comprising: a mobile sensor platform (MSP) including sensors that output sensor signals relating to parameters such as range, gravity, direction of the Earth's magnetic field, and angular velocity. The MSP is adapted to be moved through the environment. The sensor signals are processed and observations of axes in the environment are generated for a sequence of time steps, the orientation of the MSP is estimated for each of the time steps, observed axes are identified at each orientation, and similar axes are associated. The orientations, the axes in the environment, and the directions of gravity and the Earth's magnetic field are linked such that each observation is predicted based on the estimates of the orientations. An estimate of the orientations is optimized and an output of the representation of the physical environment is generated based on the optimized orientation estimates.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: January 18, 2022
    Assignee: Queen's University at Kingston
    Inventors: Marc Gallant, Joshua Marshall
  • Patent number: 11197931
    Abstract: The invention provides liquid injectable copolymers of TMC and HTMC that are degradable in vivo. Degradation can be tailored by adjusting the amount of HTMC in the copolymer, the initial molecular weight of the copolymer, and the characteristics of the initiator used in its preparation. Specifically, the degradation rate increases as the amount of HTMC incorporated into the copolymer increases, as the molecular weight of the copolymer decreases, and as the hydrophobicity of the initiator decreases. Moreover, the degradation yields products such as glycerol and carbon dioxide that are non-toxic in vivo, and which will not cause a substantive change in tissue pH upon implantation in vivo. The copolymers may be used in applications such as drug delivery and as coatings.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: December 14, 2021
    Assignee: Queen's University at Kingston
    Inventors: Sara Mohajeri, Brian G. Amsden, Fei Chen
  • Patent number: 11168064
    Abstract: The present invention relates to the preparation of compounds of Formula I, including thapsigargin, nortrilobolide and 8-O-debutanoyl-thapsigargin from commercially available (R)-(?)-carvone via synthetic intermediate compound of formula 12 by pinacol coupling and in situ lactonization.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: November 9, 2021
    Assignee: Queen's University at Kingston
    Inventors: P. Andrew Evans, Dezhi Chen
  • Publication number: 20210323844
    Abstract: A forward osmosis system is disclosed which use a polymer switchable between a neutral form and an ionized form. The switchable polymer has a higher osmotic pressure at the ionized form than the neutral form, the ratio between the former and the latter is ?2. There is also disclosed a method for treating the polymer such that the ratio is improved. Use of polymers for forward osmosis is also disclosed.
    Type: Application
    Filed: August 23, 2019
    Publication date: October 21, 2021
    Applicants: Queen's University at Kingston, Forward Water Technologies
    Inventors: Philip G. Jessop, Michael Cunningham, Pascale Champagne, Sarah Ellis, Ryan Dykeman, Charles Honeyman, Amy Holland, Tobias Robert, Bhanu Mudraboyina
  • Patent number: 11131650
    Abstract: A method of facilitating ultrasonic analysis of a subject is provided. The method involves producing signals for causing a set of outgoing ultrasonic signals to be transmitted to the subject, wherein the set of outgoing ultrasonic signals is defined at least in part by a variable imaging parameter that varies over time in accordance with a variable imaging parameter function, the variable imaging parameter function represented or representable at least in part by a function characteristic, receiving signals representing a time dependent representation of the subject generated from a set of received ultrasonic signals scattered by the subject, determining at least one property representation of the subject based on the function characteristic and the time dependent representation of the subject, and producing signals representing the at least one property representation of the subject to facilitate analysis of the subject. Systems, non-transitory computer readable media, and other methods are also provided.
    Type: Grant
    Filed: March 18, 2021
    Date of Patent: September 28, 2021
    Assignees: The University of British Columbia, Queen's University at Kingston
    Inventors: Purang Abolmaesumi, Parvin Mousavi